![]() |
市場調查報告書
商品編碼
2041839
醫用輻射探測市場預測——全球產品類型、檢測器類型、安全措施、應用、最終用戶和地區分析——2034年Medical Radiation Detection Market Forecasts to 2034 - Global Analysis By Product, By Detector Type, Safety Type, Application, End User and By Geography |
||||||
全球醫療輻射探測市場預計到 2026 年將達到 13.578 億美元,並在預測期內以 9.5% 的複合年成長率成長,到 2034 年達到 28.064 億美元。
醫用輻射檢測是指利用專用設備對醫療環境中的電離輻射水平進行監測、測量和檢測。這些設備能夠追蹤輻射暴露情況,並評估X光、 電腦斷層掃描和放射治療等治療過程中的輻射劑量,從而確保安全,保護患者和醫護人員免受過度輻射。
根據英國國家醫療服務體系(NHS England)的數據,2018 年 3 月英格蘭共登記了 4,270 萬次影像檢查,比 2017 年的 4,210 萬次增加了 1.4%。
擴大核子醫學和放射療法的應用
核子醫學和放射療法在各種疾病的診斷和治療中日益普及,推動了對先進醫用輻射探測技術的需求。這些技術,例如PET掃描、SPECT掃描和放射療法,都依賴電離輻射。隨著其應用範圍的擴大,對高精度、高靈敏度的探測系統的需求也隨之成長,這些系統用於監測輻射水平、確保劑量精準輸送,並保障患者和醫護人員的安全。這種需求的激增,正推動醫用輻射探測市場的創新和投資,其驅動力在於對更有效率、更可靠的探測解決方案的追求。
設備高成本
先進的技術和嚴格的監管標準推高了輻射探測設備的研發、製造和維護成本。這些成本通常轉嫁給醫療機構,使得小規模診所和資源匱乏的機構難以採用最先進的偵測系統。這種經濟障礙限制了設備的普及,阻礙了尖端探測技術的獲取,並可能對醫療機構輻射安全措施的整體有效性產生負面影響。
遠端醫療
遠端醫療的普及,尤其是與遠距離診斷和治療的融合,為醫用輻射探測市場創造了新的機會。隨著遠端醫療的擴展,對精準輻射監測工具的需求日益成長。這些設備對於確保患者安全至關重要,它們能夠遠端評估遠距遠端醫療過程中(包括影像和放射治療)的輻射暴露。以遠端醫療環境為導向的輻射探測技術創新,為企業提供了開發高度便攜、易於使用且精準的檢測器的機會,從而滿足這一不斷發展的市場需求。
開發中國家缺乏意識
教育和資源的匱乏阻礙了適當輻射安全措施的實施以及對探測技術的理解。這增加了患者和醫護人員過度暴露於輻射的風險,並可能對其健康造成影響。此外,缺乏嚴格的監管和基礎設施投資不足加劇了這個問題,可能導致輻射相關健康併發症的發生率升高,而對先進探測解決方案的需求不足也可能阻礙市場成長。
新冠疫情透過醫療服務中斷和非緊急手術延期,對醫用輻射探測市場造成了衝擊。供應鏈中斷影響了探測設備的供應,可能導致供不應求。此外,醫療預算限制也減緩了先進探測技術的應用。疫情相關優先事項的集中導致人們對輻射安全問題的關注度下降,從而影響了危機期間的市場動態和成長。
在預測期內,氣體填充式檢測器細分市場預計將成為最大的細分市場。
由於氣體填充式檢測器具有高靈敏度、高可靠性和多功能性,能夠探測各種類型的輻射,預計將在醫用輻射探測市場佔據主導地位。它們能夠即時、精確地測量各種醫療程序(例如X光和核醫學)中的輻射水平,這促進了它們的廣泛應用。此外,氣體填充式檢測器技術的進步正在提高輻射偵測的效率和準確性,同時確保成本效益,進一步鞏固了該領域在預期市場成長軌跡中的主導地位。
在預測期內,全身防護裝備細分市場預計將呈現最高的複合年成長率。
由於人們對醫療過程中輻射暴露的擔憂日益加劇,全身防護產品領域預計將呈現最高的複合年成長率。醫護人員對輻射長期風險的認知不斷提高,推動了對全面防護工具的需求成長。隨著安全規程日益嚴格,對包括遮光罩和防護設備在內的先進全身防護產品的需求也不斷增加。旨在最大限度減少輻射暴露的強效輻射屏蔽解決方案的需求激增,預計將推動該領域的快速成長。
北美預計將佔據最大的市場佔有率,這得益於其先進的醫療基礎設施、最尖端科技的高普及率以及嚴格的安全法規。該地區完善的醫療體系高度重視輻射安全規程,推動了對先進檢測設備的需求。此外,主要市場參與者的存在以及持續的研發活動也鞏固了北美的市場主導地位。
由於技術的快速發展、醫療基礎設施的不斷完善以及人們對輻射安全措施日益增強的意識,亞太地區預計將迎來顯著的市場成長。這些因素正在推動市場擴張。此外,需要進行放射線診斷和治療的慢性疾病盛行率不斷上升,也刺激了市場需求。同時,各國政府致力於醫療現代化和推廣先進醫療技術的舉措,也進一步推動了市場發展。
According to Stratistics MRC, the Global Medical Radiation Detection Market is accounted for $1357.8 million in 2026 and is expected to reach $2806.4 million by 2034 growing at a CAGR of 9.5% during the forecast period. Medical radiation detection involves the use of specialised devices to monitor, measure and detect ionising radiation levels in medical settings. These instruments ensure safety by tracking radiation exposure, assessing dosage during treatments like X-rays, CT scans, or radiation therapy and safeguarding both patients and healthcare professionals from potential overexposure to radiation.
According to NHS England, 42.7 million imaging tests were registered in England in March 2018, compared to 42.1 million in 2017, an increase of 1.4%.
Growing usage of nuclear medicine and radiation therapy
The increasing adoption of nuclear medicine and radiation therapy in diagnosing and treating various medical conditions has fueled the demand for advanced medical radiation detection technologies. These modalities, such as PET scans, SPECT scans, and radiation therapy, rely on ionising radiation. As their usage grows, there's a parallel need for precise and sensitive detection systems to monitor radiation levels, ensure accurate dosage delivery, and guarantee the safety of patients and healthcare workers. This surge propels innovation and investment in the medical radiation detection market for more efficient and reliable detection solutions.
High cost of equipment
Advanced technology and stringent regulatory standards drive up the expenses associated with developing, manufacturing, and maintaining radiation detection devices. These costs often trickle down to healthcare facilities, making it challenging for smaller clinics or resource-limited settings to afford cutting-edge detection systems. This financial barrier limits widespread adoption, hindering accessibility to state-of-the-art detection technology and potentially impacting the overall effectiveness of radiation safety measures in medical settings.
Growing adoption of telehealth
The growing adoption of telehealth presents an opportunity in the medical radiation detection market due to its integration with remote diagnostics and treatments. As telehealth expands, there is a need for accurate radiation monitoring tools. These devices become crucial in ensuring patient safety by remotely assessing radiation exposure during telemedicine sessions involving imaging or radiation therapies. Innovations in radiation detection technologies catering to telehealth settings offer a chance for companies to develop portable, user-friendly, and precise detectors, thereby tapping into this evolving market demand.
Lack of awareness in developing countries
Limited education and resources hinder the adoption of proper radiation safety measures and the understanding of detection technologies. This can lead to increased risks of overexposure to radiation for both patients and healthcare workers, impacting their health. Additionally, the absence of stringent regulations and insufficient infrastructure investment further exacerbate this issue, potentially resulting in higher incidences of radiation-related health complications and impeding the market's growth due to a lack of demand for advanced detection solutions.
The COVID-19 pandemic has impacted the medical radiation detection market by disrupting healthcare services and delaying non-essential procedures. Supply chain disruptions affected the availability of detection devices, leading to potential shortages. Additionally, financial constraints on healthcare budgets slowed down the adoption of advanced detection technologies. The focus on pandemic-related priorities shifted attention away from radiation safety concerns, influencing market dynamics and growth during the crisis period.
The gas-filled detectors segment is expected to be the largest during the forecast period
Gas-filled detectors are projected to dominate the medical radiation detection market due to their high sensitivity, reliability and versatility in detecting various types of radiation. Their ability to precisely measure radiation levels in real-time across different medical procedures, such as X-rays and nuclear medicine, contributes to their widespread adoption. Additionally, advancements in gas-filled detector technology, offering improved efficiency and accuracy in radiation detection while ensuring cost-effectiveness, further solidify their position as the leading segment in the market's forecasted growth trajectory.
The full-body protection segment is expected to have the highest CAGR during the forecast period
The full-body protection segment is anticipated to demonstrate the highest CAGR due to escalating concerns regarding radiation exposure across medical procedures. Heightened awareness about the long-term risks of radiation has amplified the demand for comprehensive protective gear among healthcare professionals. As safety protocols become more stringent, the need for advanced, full-body protection, encompassing shielding garments and equipment, is increasing. This surge in demand for robust radiation shielding solutions, aimed at minimising radiation exposure, is projected to drive the segment's rapid growth.
North America is poised to claim the largest market share, owing to its advanced healthcare infrastructure, high adoption of cutting-edge technologies and stringent safety regulations. The region's well-established healthcare systems emphasise radiation safety protocols, propelling the demand for sophisticated detection devices. Additionally, the presence of key market players and continuous research and development activities contribute to the dominance of North America.
The Asia-Pacific region is poised for substantial growth in the market due to rapid technological advancements, increasing healthcare infrastructure development and rising awareness about radiation safety measures, which are driving market expansion. Additionally, the growing prevalence of chronic diseases requiring radiation-based diagnostic and therapeutic procedures fuels demand. Moreover, governmental initiatives focusing on healthcare modernization and the adoption of advanced medical technologies further propel the market.
Key players in the market
Some of the key players in Medical Radiation Detection Market include AmRay Medical, Anritsu Infivis, Arrow-Tech, Inc., Berthold Technologies, Biodex Medical Systems, Eckert & Ziegler, Fluke Biomedical, IBA Dosimetry, Landauer, Inc., Ludlum Measurements, Inc., Mirion Technologies Inc, Polimaster, Radiation Detection Company, S.E. International, Inc., Saphymo, Sun Nuclear Corporation and Thermo Fisher Scientific.
In November 2023, Mirion, announced that it will debut the new Instadose(R)VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting starting Sunday in Chicago, Illinois. Mirion Dosimetry Services joins Sun Nuclear, Capintec, and Biodex medical imaging brands in the Mirion Medical booth (#6328) at RSNA, which will feature products and services for occupational dosimetry, diagnostic imaging QA, nuclear medicine, and medical imaging tables and accessories.
In November 2023, Thermo Fisher Scientific Inc., the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis.
In October 2023, Thermo Fisher Scientific Inc. ("Thermo Fisher"), the world leader in serving science, and Olink Holding AB (publ) ("Olink"), a leading provider of next-generation proteomics solutions, today announced that their respective boards of directors have approved Thermo Fisher's proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.